Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional

Efficacy Evaluation of Enobosarm Monotherapy in Treatment of AR+/ER+/HER2- Metastatic Breast Cancer

ClinicalTrials.gov ID: NCT04869943

Public ClinicalTrials.gov record NCT04869943. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 4:35 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized Crossover Ph3 to Evaluate Efficacy/Safety of Enobosarm Monotherapy vs Active Control for Treatment of AR+/ER+/HER2- MBC With AR Staining Previously Treated w/Nonsteroidal Aromatase Inhibitor, SERD & CDK 4/6 Inhibitor

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To demonstrate the efficacy of enobosarmin the treatment of androgen receptor positive (AR+) and estrogen receptor positive (ER+) metastatic breast cancer (MBC) as measured by radiographic progression free survival (rPFS).

Study identification

NCT ID
NCT04869943
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Veru Inc.
Industry
Enrollment
52 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 100 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 12, 2021 (Actual)
Primary completion
Jan 9, 2024 (Actual)
Completion
Jan 9, 2024 (Actual)
Last update posted
Jan 26, 2024

2021 – 2024

United States locations

U.S. sites
34
U.S. states
17
U.S. cities
32
Facility City State ZIP Site status
Ironwood Cancer and Research Centers Chandler Arizona 85224 —
Banner Health/ Banner MD Anderson Cancer Center Gilbert Arizona 85234 —
The Oncology Insitute of Hope and Innovation Glendale California 91204 —
Marin Cancer Care, Inc. Greenbrae California 94904 —
California Research Institute (CRI) Los Angeles California 90027 —
University of California San Francisco Comprehensive Cancer Center San Francisco California 94158 —
Providence Medical Group Santa Rosa California 95043 —
Rocky Mountain Cancer Centers Denver Colorado 81008 —
Morton Plant Hospital/ BayCare Health System, Inc Clearwater Florida 33756 —
University of Miami- Sylvester Comprehensive Cancer Center Miami Florida 33146 —
Miami Cancer Institute Miami Florida 33176 —
Woodlands Medical Specialists, PA Pensacola Florida 32503 —
Miami Cancer Institute, Plantation MCIP Plantation Florida 33324 —
University Cancer & Blood Center Athens Georgia 30607 —
Blessing Corporate Services Quincy Illinois 62301 —
MBCCOP - LSU Health Sciences Center Shreveport Louisiana 71103 —
Dana-Farber Cancer Institute Breast Oncology Boston Massachusetts 02215 —
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 89169 —
Astera Cancer Care East Brunswick New Jersey 08816 —
Inspira Medical Center Mullica Hill Mullica Hill New Jersey 08062 —
Inspira Medical Center Vineland New Jersey 08360 —
The Lindner Center for Research and Education at the Christ Hospital Cincinnati Ohio 45219 —
Magee-Women's Hospital Pittsburgh Pennsylvania 15219 —
Tidelands Health Murrells Inlet South Carolina 29576 —
Tennessee Cancer Specialists Knoxville Tennessee 37909 —
Baptist Clinical Research Institute Nashville Tennessee 38102 —
Texas Oncology Sammons Cancer Center Dallas Texas 75246 —
Texas Oncology - Tyler Tyler Texas 75702 —
Virginia Cancer Specialists Fairfax Virginia 22031 —
Virginia Oncology Associates Norfolk Virginia 23502 —
Oncology and Hematology Associates of Southwest Virginia, Inc. Roanoke Virginia 24014 —
MultiCare Institute for Research and Innovation Puyallup Washington 98372 —
Cancer Care Northwest Spokane Washington 99216 —
MultiCare Institute for Research and Innovation Spokane Washington 99218 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 20 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04869943, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 26, 2024 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04869943 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →